Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

The research confirmed that certain methods are reliable for standardizing Eclipta alba and ensuring its safety and quality in herbal products.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

Letrozole may help prevent seizures by reducing certain hormone levels.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Ruxolitinib cream may help treat severe hair loss in children.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Baricitinib is a promising treatment for alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.